A bioinformatics study of structural perturbation of 3CL-protease and the HR2-domain of SARS-CoV-2 induced by synergistic interaction with ivermectins

Article

Abstract: The pandemic caused by SARS-CoV-2 forces drug research to combat it. Ivermectin, an FDA approved ant

Palabras claves:

covid-19, Ivermectin, Molecular docking, molecular dynamics, SARS-COV-2

Autores:

Alvarado Y.J., González-Paz L.A., Joan R. Vera V., Joan Vera-Villalobos, José Luis Paz, Lossada C.A., Luis S. Moncayo, Pérez A.E., Portillo E., Romero F., San-Blas E.

Fuentes:

google

scopus